A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 4

A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44 (ELEVATE-44)

Open

Protocol code: ENTR-601-44-201
EudraCT code: No aplica
Research group: Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Service: General Pediatrics and Specialties
Principal investigator: Gómez Andrés, David
Pathology: Malalties del sistema nerviós
Phase: Fase I